25 XP   0   0   10

Acumen Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Acumen Pharmaceuticals Inc together

PenkeI guess you are interested in Acumen Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Acumen Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Acumen Pharmaceuticals Inc

I send you an email if I find something interesting about Acumen Pharmaceuticals Inc.

Quick analysis of Acumen Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Acumen Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.61
Expected worth in 1 year
$5.96
How sure are you?
12.5%

+ What do you gain per year?

Total Gains per Share
$1.35
Return On Investment
42.3%

For what price can you sell your share?

Current Price per Share
$3.19
Expected price per share
$2.19 - $4.57
How sure are you?
50%

1. Valuation of Acumen Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$3.19

Intrinsic Value Per Share

$-8.57 - $-10.09

Total Value Per Share

$-3.96 - $-5.48

2. Growth of Acumen Pharmaceuticals Inc (5 min.)




Is Acumen Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$266.9m$202m$21.7m9.7%

How much money is Acumen Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$12.6m-$10.7m-$1.9m-15.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Acumen Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#191 / 1010

Most Revenue
#904 / 1010

Most Profit
#601 / 1010

Most Efficient
#346 / 1010

What can you expect buying and holding a share of Acumen Pharmaceuticals Inc? (5 min.)

Welcome investor! Acumen Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Acumen Pharmaceuticals Inc.

What can you expect buying and holding a share of Acumen Pharmaceuticals Inc?

First you should know what it really means to hold a share of Acumen Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Acumen Pharmaceuticals Inc is $3.19. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Acumen Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Acumen Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.61. Based on the TTM, the Book Value Change Per Share is $0.34 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Acumen Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.28-8.9%-0.23-7.1%-0.19-5.8%-0.22-6.9%-0.22-6.9%
Usd Book Value Change Per Share-0.23-7.2%0.3410.6%-0.16-4.9%0.299.0%0.299.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.23-7.2%0.3410.6%-0.16-4.9%0.299.0%0.299.0%
Usd Price Per Share3.84-4.22-6.01-3.91-3.91-
Price to Earnings Ratio-3.37--4.80--8.13--7.41--7.41-
Price-to-Total Gains Ratio-16.72--16.53--37.98--26.34--26.34-
Price to Book Ratio0.83-1.16-1.74-1.07-1.07-
Price-to-Total Gains Ratio-16.72--16.53--37.98--26.34--26.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.19
Number of shares313
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.340.29
Usd Total Gains Per Share0.340.29
Gains per Quarter (313 shares)105.6690.19
Gains per Year (313 shares)422.65360.74
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104234130361351
208458360721712
3012681259010821073
4016911682014431434
5021132105018041795
6025362528021642156
7029592951025252517
8033813374028862878
9038043797032473239
10042274220036073600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.016.00.00.0%0.016.00.00.0%0.016.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%2.011.03.012.5%2.011.03.012.5%2.011.03.012.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.016.00.0%0.00.016.00.0%0.00.016.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%2.011.03.012.5%2.011.03.012.5%2.011.03.012.5%

Fundamentals of Acumen Pharmaceuticals Inc

About Acumen Pharmaceuticals Inc

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Fundamental data was last updated by Penke on 2024-04-10 23:20:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Acumen Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Acumen Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-165.4%+165.4%
5Y-165.4%10Y-165.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.3%+282.3%
5Y-165.4%-436.8%+271.4%
10Y-165.4%-597.3%+431.9%
1.1.2. Return on Assets

Shows how efficient Acumen Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • -5.3% Return on Assets means that Acumen Pharmaceuticals Inc generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Acumen Pharmaceuticals Inc:

  • The MRQ is -5.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-5.4%+0.0%
TTM-5.4%YOY-5.2%-0.2%
TTM-5.4%5Y-12.3%+7.0%
5Y-12.3%10Y-12.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-13.3%+8.0%
TTM-5.4%-12.8%+7.4%
YOY-5.2%-11.6%+6.4%
5Y-12.3%-13.8%+1.5%
10Y-12.3%-15.6%+3.3%
1.1.3. Return on Equity

Shows how efficient Acumen Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • -6.2% Return on Equity means Acumen Pharmaceuticals Inc generated $-0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Acumen Pharmaceuticals Inc:

  • The MRQ is -6.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.2%TTM-5.7%-0.4%
TTM-5.7%YOY-5.4%-0.4%
TTM-5.7%5Y-3.1%-2.6%
5Y-3.1%10Y-3.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.2%-16.9%+10.7%
TTM-5.7%-16.1%+10.4%
YOY-5.4%-14.9%+9.5%
5Y-3.1%-19.3%+16.2%
10Y-3.1%-20.1%+17.0%

1.2. Operating Efficiency of Acumen Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Acumen Pharmaceuticals Inc is operating .

  • Measures how much profit Acumen Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-168.0%+168.0%
5Y-168.0%10Y-168.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--288.4%+288.4%
5Y-168.0%-486.2%+318.2%
10Y-168.0%-628.4%+460.4%
1.2.2. Operating Ratio

Measures how efficient Acumen Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.867-1.867
5Y1.86710Y1.8670.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.838-3.838
5Y1.8675.679-3.812
10Y1.8677.823-5.956

1.3. Liquidity of Acumen Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Acumen Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 19.01 means the company has $19.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 19.013. The company is very able to pay all its short-term debts. +2
  • The TTM is 22.199. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ19.013TTM22.199-3.186
TTM22.199YOY34.933-12.734
TTM22.1995Y26.793-4.594
5Y26.79310Y26.7930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.0133.863+15.150
TTM22.1994.169+18.030
YOY34.9335.337+29.596
5Y26.7936.122+20.671
10Y26.7936.434+20.359
1.3.2. Quick Ratio

Measures if Acumen Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 32.41 means the company can pay off $32.41 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 32.409. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 33.958. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ32.409TTM33.958-1.549
TTM33.958YOY46.714-12.756
TTM33.9585Y35.962-2.003
5Y35.96210Y35.9620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ32.4093.504+28.905
TTM33.9583.991+29.967
YOY46.7145.371+41.343
5Y35.9626.088+29.874
10Y35.9626.395+29.567

1.4. Solvency of Acumen Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Acumen Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Acumen Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14 means that Acumen Pharmaceuticals Inc assets are financed with 13.9% credit (debt) and the remaining percentage (100% - 13.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 0.139. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.064. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.139TTM0.064+0.075
TTM0.064YOY0.029+0.035
TTM0.0645Y0.397-0.333
5Y0.39710Y0.3970.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1390.339-0.200
TTM0.0640.337-0.273
YOY0.0290.271-0.242
5Y0.3970.368+0.029
10Y0.3970.388+0.009
1.4.2. Debt to Equity Ratio

Measures if Acumen Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 16.2% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Acumen Pharmaceuticals Inc:

  • The MRQ is 0.162. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.071. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.162TTM0.071+0.091
TTM0.071YOY0.030+0.041
TTM0.0715Y0.027+0.044
5Y0.02710Y0.0270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1620.392-0.230
TTM0.0710.403-0.332
YOY0.0300.335-0.305
5Y0.0270.427-0.400
10Y0.0270.461-0.434

2. Market Valuation of Acumen Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Acumen Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Acumen Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -3.37 means the investor is paying $-3.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Acumen Pharmaceuticals Inc:

  • The EOD is -2.800. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.370. Based on the earnings, the company is expensive. -2
  • The TTM is -4.801. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.800MRQ-3.370+0.570
MRQ-3.370TTM-4.801+1.431
TTM-4.801YOY-8.135+3.334
TTM-4.8015Y-7.412+2.612
5Y-7.41210Y-7.4120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.800-2.300-0.500
MRQ-3.370-2.656-0.714
TTM-4.801-2.718-2.083
YOY-8.135-4.145-3.990
5Y-7.412-6.258-1.154
10Y-7.412-6.315-1.097
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Acumen Pharmaceuticals Inc:

  • The EOD is -5.546. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.676. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.768. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.546MRQ-6.676+1.130
MRQ-6.676TTM-5.768-0.907
TTM-5.768YOY-9.977+4.209
TTM-5.7685Y-7.352+1.584
5Y-7.35210Y-7.3520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.546-2.974-2.572
MRQ-6.676-3.306-3.370
TTM-5.768-3.508-2.260
YOY-9.977-5.613-4.364
5Y-7.352-8.378+1.026
10Y-7.352-8.873+1.521
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Acumen Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.83 means the investor is paying $0.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Acumen Pharmaceuticals Inc:

  • The EOD is 0.692. Based on the equity, the company is cheap. +2
  • The MRQ is 0.833. Based on the equity, the company is cheap. +2
  • The TTM is 1.163. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.692MRQ0.833-0.141
MRQ0.833TTM1.163-0.330
TTM1.163YOY1.744-0.581
TTM1.1635Y1.066+0.097
5Y1.06610Y1.0660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6921.914-1.222
MRQ0.8332.116-1.283
TTM1.1632.097-0.934
YOY1.7442.881-1.137
5Y1.0663.550-2.484
10Y1.0663.936-2.870
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Acumen Pharmaceuticals Inc.

3.1. Institutions holding Acumen Pharmaceuticals Inc

Institutions are holding 75.179% of the shares of Acumen Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC25.78470.89561493206300
2023-12-31Sands Capital Ventures, LLC5.90063.6503341707500
2023-12-31Franklin Resources Inc5.80.006335880952004418.3194
2023-12-31Rock Springs Capital Management LP3.97180.21742300059-512520-18.2224
2023-09-30LAURION CAPITAL MANAGEMENT LP3.27230.048189502368847557.0616
2023-12-31Vanguard Group Inc3.17650.00021839552-17000-0.9157
2023-12-31Knollwood Investment Advisory LLC2.81211.3004162851000
2023-12-31Millennium Management LLC2.58210.00251495284-221006-12.877
2023-09-30Schonfeld Strategic Advisors LLC1.1140.02086451126451120
2023-09-30Alyeska Investment Group, L.P.1.060.01736138226138220
2023-12-31JANE STREET GROUP, LLC1.04410.00066046205878323501.5011
2023-12-31Parkman Healthcare Partners LLC1.04210.326460349710368320.7443
2023-12-31Hudson Bay Capital Management LP0.97460.0137564400-485600-46.2476
2023-12-31Susquehanna International Group, LLP0.8630.0004499794322015181.1322
2023-12-31Pathstone Holdings LLC0.82740.00994791494791490
2023-09-30Pathstone Family Office, LLC0.82680.0152478790117302.5115
2023-12-31Ikarian Capital, LLC0.54440.113431526500
2023-12-31Geode Capital Management, LLC0.45690.000126460300
2023-12-31BlackRock Inc0.42840248095-335319-57.4753
2023-12-31Two Sigma Investments LLC0.42210.002224441611206584.6726
Total 62.90396.640436427938+2512482+6.9%

3.2. Funds holding Acumen Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Franklin Biotechnology Discv A(acc)USD2.4610.3453147858600
2024-02-29Franklin Small Cap Growth Adv1.99780.1784120030000
2023-12-31Franklin US Small Cap Growth Equity1.99780.1663120030000
2024-02-29Vanguard Total Stock Mkt Idx Inv1.90520.00031144635-174494-13.228
2024-02-29Fidelity Select Health Care1.66450.0545100000000
2024-02-29Franklin Biotechnology Discovery A1.12180.30267400000
2024-02-29Fidelity Advisor Health Care I0.99870.05260000000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.78590.00247217200
2024-02-29Fidelity Extended Market Index0.24570.0017147593-715-0.4821
2024-02-29Fidelity VIP Health Care Initial0.2330.050914000000
2024-03-31A4Investments SICAV SIF ACCI IlanaA2EURH0.19145.0792115000100009.5238
2024-02-29Fidelity Stock Selec All Cp0.1530.0065918939571.0524
2024-03-28iShares Micro-Cap ETF0.14250.03778563200
2024-02-29Fidelity VIP Stock Selector All Cap Init0.11480.00656900000
2023-09-30BlackRock Extended Mkt Composite0.10960.00196587443088189.0986
2024-03-31BlackRock Extended Equity Market K0.09570.001657490210.0365
2024-01-31Fidelity Asset Manager 50%0.08410.001750515505150
2024-02-29Vifag 2002 SICAV0.08320.33685000000
2024-01-31Fidelity Asset Manager 70%0.07510.002245090450900
2024-02-29Fidelity Total Market Index0.07120.00024279200
Total 14.5326.62778730872-25538-0.3%

3.3. Insider Transactions

Insiders are holding 9.468% of the shares of Acumen Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-19Daniel Joseph OconnellSELL152003.47
2024-01-19Derek M MeisnerSELL89333.48
2024-01-18Matt ZugaSELL42423.71
2024-01-18Russell BartonSELL28333.73
2023-08-17Jeffrey L. IvesSELL419496.49
2023-07-21Ra Capital Management, L.p.BUY51612907.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Acumen Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2300.338-168%-0.157-32%0.288-180%0.288-180%
Book Value Per Share--4.6103.865+19%3.488+32%2.149+114%2.149+114%
Current Ratio--19.01322.199-14%34.933-46%26.793-29%26.793-29%
Debt To Asset Ratio--0.1390.064+118%0.029+385%0.397-65%0.397-65%
Debt To Equity Ratio--0.1620.071+129%0.030+446%0.027+501%0.027+501%
Dividend Per Share----0%-0%-0%-0%
Eps---0.285-0.226-21%-0.185-35%-0.219-23%-0.219-23%
Free Cash Flow Per Share---0.144-0.186+29%-0.152+6%-0.112-22%-0.112-22%
Free Cash Flow To Equity Per Share--0.3590.468-23%-0.136+138%0.457-21%0.457-21%
Gross Profit Margin--1.0021.001+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---10.087--------
Intrinsic Value_10Y_min---8.574--------
Intrinsic Value_1Y_max---0.622--------
Intrinsic Value_1Y_min---0.610--------
Intrinsic Value_3Y_max---2.165--------
Intrinsic Value_3Y_min---2.060--------
Intrinsic Value_5Y_max---4.065--------
Intrinsic Value_5Y_min---3.747--------
Market Cap184734495.000-20%222376320.000244092757.500-9%348042105.000-36%226285278.750-2%226285278.750-2%
Net Profit Margin----0%-0%-1.6540%-1.6540%
Operating Margin----0%-0%-1.6800%-1.6800%
Operating Ratio----0%-0%1.867-100%1.867-100%
Pb Ratio0.692-20%0.8331.163-28%1.744-52%1.066-22%1.066-22%
Pe Ratio-2.800+17%-3.370-4.801+42%-8.135+141%-7.412+120%-7.412+120%
Price Per Share3.190-20%3.8404.215-9%6.010-36%3.908-2%3.908-2%
Price To Free Cash Flow Ratio-5.546+17%-6.676-5.768-14%-9.977+49%-7.352+10%-7.352+10%
Price To Total Gains Ratio-13.890+17%-16.720-16.526-1%-37.976+127%-26.335+58%-26.335+58%
Quick Ratio--32.40933.958-5%46.714-31%35.962-10%35.962-10%
Return On Assets---0.053-0.054+1%-0.052-2%-0.123+131%-0.123+131%
Return On Equity---0.062-0.057-7%-0.054-13%-0.031-50%-0.031-50%
Total Gains Per Share---0.2300.338-168%-0.157-32%0.288-180%0.288-180%
Usd Book Value--266973000.000223801250.000+19%202008500.000+32%124478125.000+114%124478125.000+114%
Usd Book Value Change Per Share---0.2300.338-168%-0.157-32%0.288-180%0.288-180%
Usd Book Value Per Share--4.6103.865+19%3.488+32%2.149+114%2.149+114%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.285-0.226-21%-0.185-35%-0.219-23%-0.219-23%
Usd Free Cash Flow---8328000.000-10771250.000+29%-8828500.000+6%-6490250.000-22%-6490250.000-22%
Usd Free Cash Flow Per Share---0.144-0.186+29%-0.152+6%-0.112-22%-0.112-22%
Usd Free Cash Flow To Equity Per Share--0.3590.468-23%-0.136+138%0.457-21%0.457-21%
Usd Market Cap184734495.000-20%222376320.000244092757.500-9%348042105.000-36%226285278.750-2%226285278.750-2%
Usd Price Per Share3.190-20%3.8404.215-9%6.010-36%3.908-2%3.908-2%
Usd Profit---16497000.000-12635750.000-23%-10714000.000-35%-12583125.000-24%-12583125.000-24%
Usd Revenue----0%-0%158937.500-100%158937.500-100%
Usd Total Gains Per Share---0.2300.338-168%-0.157-32%0.288-180%0.288-180%
 EOD+3 -5MRQTTM+11 -19YOY+12 -185Y+10 -2210Y+10 -22

4.2. Fundamental Score

Let's check the fundamental score of Acumen Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.800
Price to Book Ratio (EOD)Between0-10.692
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than132.409
Current Ratio (MRQ)Greater than119.013
Debt to Asset Ratio (MRQ)Less than10.139
Debt to Equity Ratio (MRQ)Less than10.162
Return on Equity (MRQ)Greater than0.15-0.062
Return on Assets (MRQ)Greater than0.05-0.053
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Acumen Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.063
Ma 20Greater thanMa 503.600
Ma 50Greater thanMa 1003.837
Ma 100Greater thanMa 2003.596
OpenGreater thanClose3.110
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -751227-524-122-646137-509821312



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets310,125
Total Liabilities43,152
Total Stockholder Equity266,973
 As reported
Total Liabilities 43,152
Total Stockholder Equity+ 266,973
Total Assets = 310,125

Assets

Total Assets310,125
Total Current Assets246,615
Long-term Assets63,510
Total Current Assets
Cash And Cash Equivalents 66,886
Short-term Investments 176,636
Net Receivables 225
Other Current Assets 2,868
Total Current Assets  (as reported)246,615
Total Current Assets  (calculated)246,615
+/- 0
Long-term Assets
Property Plant Equipment 503
Long Term Investments 62,553
Long-term Assets Other 221
Long-term Assets  (as reported)63,510
Long-term Assets  (calculated)63,277
+/- 233

Liabilities & Shareholders' Equity

Total Current Liabilities12,971
Long-term Liabilities30,181
Total Stockholder Equity266,973
Total Current Liabilities
Short-term Debt 866
Accounts payable 1,379
Other Current Liabilities 10,726
Total Current Liabilities  (as reported)12,971
Total Current Liabilities  (calculated)12,971
+/-0
Long-term Liabilities
Long term Debt 27,337
Capital Lease Obligations 1,150
Long-term Liabilities  (as reported)30,181
Long-term Liabilities  (calculated)28,487
+/- 1,694
Total Stockholder Equity
Common Stock6
Retained Earnings -222,798
Accumulated Other Comprehensive Income 312
Other Stockholders Equity 489,453
Total Stockholder Equity (as reported)266,973
Total Stockholder Equity (calculated)266,973
+/-0
Other
Capital Stock6
Cash and Short Term Investments 243,522
Common Stock Shares Outstanding 57,910
Liabilities and Stockholders Equity 310,125
Net Debt -35,839
Net Invested Capital 294,310
Net Working Capital 233,644
Property Plant and Equipment Gross 503
Short Long Term Debt Total 31,047



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
44,429
42,373
72,943
234,849
230,330
220,087
211,678
203,264
196,587
187,864
177,405
286,371
310,125
310,125286,371177,405187,864196,587203,264211,678220,087230,330234,84972,94342,37344,429000
   > Total Current Assets 
0
0
0
44,429
42,103
70,572
204,913
198,661
192,098
191,053
202,560
180,329
144,032
149,538
218,598
246,615
246,615218,598149,538144,032180,329202,560191,053192,098198,661204,91370,57242,10344,429000
       Cash And Cash Equivalents 
0
0
0
43,777
41,407
68,812
135,802
122,162
108,764
111,067
157,540
130,101
77,999
77,248
94,917
66,886
66,88694,91777,24877,999130,101157,540111,067108,764122,162135,80268,81241,40743,777000
       Short-term Investments 
0
0
0
0
0
0
64,162
72,075
80,326
78,844
42,654
47,504
62,410
67,633
120,517
176,636
176,636120,51767,63362,41047,50442,65478,84480,32672,07564,162000000
       Net Receivables 
0
0
0
109
109
109
109
96
158
162
1,867
1,305
0
2,710
0
225
22502,71001,3051,86716215896109109109109000
       Other Current Assets 
0
0
0
452
464
1,586
2,293
2,827
1,926
980
499
1,419
3,623
1,944
3,164
2,868
2,8683,1641,9443,6231,4194999801,9262,8272,2931,586464452000
   > Long-term Assets 
0
0
0
0
270
2,371
29,936
31,669
27,989
20,625
704
16,258
43,832
27,867
67,773
63,510
63,51067,77327,86743,83216,25870420,62527,98931,66929,9362,3712700000
       Property Plant Equipment 
0
0
0
0
0
6
13
36
252
280
275
270
218
165
125
503
5031251652182702752802523613600000
       Long Term Investments 
0
0
0
0
0
0
29,910
31,619
27,658
20,001
0
15,837
43,419
27,311
67,270
62,553
62,55367,27027,31143,41915,837020,00127,65831,61929,910000000
       Other Assets 
0
0
0
0
270
2,365
13
14
79
344
429
0
0
391
0
0
00391004293447914132,3652700000
       Deferred Long Term Asset Charges 
0
0
0
0
0
2,352
0
0
0
0
0
0
0
0
0
0
00000000002,35200000
> Total Liabilities 
0
0
0
63,020
87,835
179,022
1,489
5,147
3,998
5,159
6,613
7,812
8,779
8,531
6,098
43,152
43,1526,0988,5318,7797,8126,6135,1593,9985,1471,489179,02287,83563,020000
   > Total Current Liabilities 
0
0
0
6,367
31,182
4,518
1,489
5,147
3,936
5,134
6,613
7,812
8,779
8,531
6,098
12,971
12,9716,0988,5318,7797,8126,6135,1343,9365,1471,4894,51831,1826,367000
       Short-term Debt 
0
0
0
0
0
0
0
0
139
142
133
105
67
29
2
866
8662296710513314213900000000
       Accounts payable 
0
0
0
531
918
2,907
382
1,088
1,219
1,710
2,084
1,640
762
2,026
1,362
1,379
1,3791,3622,0267621,6402,0841,7101,2191,0883822,907918531000
       Other Current Liabilities 
0
0
0
5,836
30,264
1,611
1,107
4,059
2,578
3,282
4,396
6,067
7,950
20
4,734
10,726
10,7264,734207,9506,0674,3963,2822,5784,0591,1071,61130,2645,836000
   > Long-term Liabilities 
0
0
0
56,653
56,653
174,504
382
4,059
62
25
2,217
1,745
829
0
0
30,181
30,181008291,7452,21725624,059382174,50456,65356,653000
       Deferred Long Term Asset Charges 
0
0
0
0
0
2,352
0
0
0
0
0
0
0
0
0
0
00000000002,35200000
       Warrants
0
0
0
0
0
349,008
0
0
0
0
0
0
0
0
0
0
0000000000349,00800000
       Deferred Long Term Liability 
0
0
0
0
257
2,352
0
0
0
238
337
0
0
183
0
0
00183003372380002,3522570000
> Total Stockholder Equity
0
0
0
-18,591
-45,462
-106,079
233,360
225,183
216,089
206,519
196,651
188,775
179,085
168,874
280,273
266,973
266,973280,273168,874179,085188,775196,651206,519216,089225,183233,360-106,079-45,462-18,591000
   Common Stock
0
0
0
0
0
0
4
4
4
4
4
4
4
4
6
6
6644444444000000
   Retained Earnings Total Equity00-193,344-181,734-170,427-157,561-146,851-136,700-127,571-119,222-115,32000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-28
-231
-814
-965
-965
-751
-524
-646
-509
312
312-509-646-524-751-965-965-814-231-28000000
   Capital Surplus 
0
0
0
0
0
9,241
352,606
352,981
353,599
354,331
355,173
359,949
361,339
362,860
0
0
00362,860361,339359,949355,173354,331353,599352,981352,6069,24100000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
0
0
8,374
8,500
8,174
117,757
352,981
353,599
354,331
355,173
359,949
361,339
362,860
487,077
489,453
489,453487,077362,860361,339359,949355,173354,331353,599352,981117,7578,1748,5008,374000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-184
Gross Profit-184-184
 
Operating Income (+$)
Gross Profit-184
Operating Expense-60,954
Operating Income-61,138-61,138
 
Operating Expense (+$)
Research Development42,318
Selling General Administrative18,820
Selling And Marketing Expenses184
Operating Expense60,95461,322
 
Net Interest Income (+$)
Interest Income8,232
Interest Expense-581
Other Finance Cost-581
Net Interest Income8,232
 
Pretax Income (+$)
Operating Income-61,138
Net Interest Income8,232
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-52,371-69,905
EBIT - interestExpense = -61,719
-52,371
-51,790
Interest Expense581
Earnings Before Interest and Taxes (EBIT)-61,138-51,790
Earnings Before Interest and Taxes (EBITDA)-60,954
 
After tax Income (+$)
Income Before Tax-52,371
Tax Provision-0
Net Income From Continuing Ops-48,740-52,371
Net Income-52,371
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses61,138
Total Other Income/Expenses Net8,767-8,232
 

Technical Analysis of Acumen Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Acumen Pharmaceuticals Inc. The general trend of Acumen Pharmaceuticals Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Acumen Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Acumen Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.31 < 4.43 < 4.57.

The bearish price targets are: 2.8949 > 2.53 > 2.19.

Tweet this
Acumen Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Acumen Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Acumen Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Acumen Pharmaceuticals Inc. The current macd is -0.21637487.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Acumen Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Acumen Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Acumen Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Acumen Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartAcumen Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Acumen Pharmaceuticals Inc. The current adx is 34.89.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Acumen Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Acumen Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Acumen Pharmaceuticals Inc. The current sar is 3.86531145.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Acumen Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Acumen Pharmaceuticals Inc. The current rsi is 34.06. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Acumen Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartAcumen Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Acumen Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Acumen Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Acumen Pharmaceuticals Inc Daily Stochastic Oscillator ChartAcumen Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Acumen Pharmaceuticals Inc. The current cci is -109.32505586.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Acumen Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartAcumen Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Acumen Pharmaceuticals Inc. The current cmo is -42.63589399.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Acumen Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartAcumen Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Acumen Pharmaceuticals Inc. The current willr is -87.09677419.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Acumen Pharmaceuticals Inc Daily Williams %R ChartAcumen Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Acumen Pharmaceuticals Inc. The current atr is 0.22183552.

Acumen Pharmaceuticals Inc Daily Average True Range (ATR) ChartAcumen Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Acumen Pharmaceuticals Inc. The current obv is 100,033,241.

Acumen Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartAcumen Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Acumen Pharmaceuticals Inc. The current mfi is 22.94.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Acumen Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartAcumen Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Acumen Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Acumen Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Acumen Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.063
Ma 20Greater thanMa 503.600
Ma 50Greater thanMa 1003.837
Ma 100Greater thanMa 2003.596
OpenGreater thanClose3.110
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Acumen Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Acumen Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Acumen Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Acumen Pharmaceuticals Inc

I send you an email if I find something interesting about Acumen Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Acumen Pharmaceuticals Inc.

Receive notifications about Acumen Pharmaceuticals Inc in your mailbox!